The Indian pharmaceutical industry plans to exceed USD 120 billion by 2030. This will be driven by innovation, supportive policies, and collaboration among stakeholders. The sector has grown ...

We highlight five contrarian stocks to add to your watchlist—companies that have the potential to surprise the market and ...

US President Joe Biden's rejection of Nippon Steel's bid to acquire US Steel on national security grounds has strained ...